Sharon K. Coon
University of Arkansas for Medical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sharon K. Coon.
Cancer Nursing | 2003
Elizabeth Ann Coleman; Sharon K. Coon; Julie Hall-Barrow; Kathy C. Richards; David Gaylor; Beth Stewart
Fatigue and insomnia are problems for patients with cancer. Research findings show that aerobic exercise decreases cancer-related fatigue. Because patients with cancer who have skeletal muscle wasting may not obtain maximum benefit from aerobic exercise training, exercise programs may need to include resistance training. Thus far, testing exercise as an intervention for fatigue has focused on patients with breast cancer and excluded patients with bone metastasis. There is a need to test the feasibility and effectiveness of exercise for patients with other types of cancer and with bone involvement. The effect of aerobic and strength resistance training on the sleep of patients with cancer has not been tested. A pilot/feasibility study with a randomized controlled design was conducted to investigate homebased exercise therapy for 24 patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantation as treatment for multiple myeloma. None of the patients injured themselves. Because of the small sample size in the feasibility study, the effect of exercise on lean body weight was the only end point that obtained statistical significance. However, the results suggest that an individualized exercise program for patients receiving aggressive treatment for multiple myeloma is feasible and may be effective for decreasing fatigue and mood disturbance, and for improving sleep.
Oncology Nursing Forum | 2008
Elizabeth Ann Coleman; Sharon K. Coon; Robert L. Kennedy; Kimberly Lockhart; Carol Beth Stewart; Elias Anaissie; Bart Barlogie
PURPOSE/OBJECTIVES To determine the effect of aerobic and strength resistance training and epoetin alfa (EPO) therapy on transfusions, stem cell collections, transplantation recovery, and multiple myeloma treatment response. DESIGN Randomized clinical trial. SETTING A myeloma research and therapy center in the south central United States. SAMPLE 135 patients with multiple myeloma, 120 evaluable. METHODS Random assignment to exercise or usual care groups. All patients received EPO based on an algorithm. Aerobic capacity, using the six-minute walk test, was assessed prior to induction chemotherapy, prior to stem cell mobilization, and following stem cell collection for all patients and before and after transplantation for patients continuing in the study. Data analysis included analysis of variance to compare other outcome variables by groups. MAIN RESEARCH VARIABLES Number of red blood cell and platelet transfusions during transplantation, number of attempts at and total number of days of stem cell collection, time to recovery after transplantation, and response to intensive therapy for multiple myeloma. FINDINGS Recovery and treatment response were not significantly different between groups after transplantation. The exercise group had significantly fewer red blood cell transfusions and fewer attempts at stem cell collection. Serious adverse events were similar in each group. CONCLUSIONS Exercise with prophylactic EPO therapy reduces the number of RBC transfusions and attempts at stem cell collection for patients receiving intensive treatment for multiple myeloma. IMPLICATIONS FOR NURSING Exercise is safe and has many physiologic benefits for patients receiving multiple myeloma treatment.
Cancer Nursing | 2011
Elizabeth Ann Coleman; Julia A. Goodwin; Sharon K. Coon; Kathy C. Richards; Carol A. Enderlin; Robert L. Kennedy; Carol Beth Stewart; Paula McNatt; Kim Lockhart; Elias Anaissie; Bart Barlogie
Background: Cancer-related fatigue and insomnia are common distressing symptoms and may affect mood and performance status. Objective: The objective of this study was to describe fatigue, sleep, pain, mood, and performance status and the relationships among these variables in 187 patients with newly diagnosed multiple myeloma (MM) and conduct an analysis using the correlates of fatigue. Methods: Data were from baseline measures from the study, using the Profile of Mood States and the Functional Assessment of Cancer Therapy-Fatigue to assess fatigue, the actigraph to measure sleep, the Wong/Baker Faces Pain Rating Scale to assess pain, the Profile of Mood States to assess mood, and the 6-minute walk test along with a back/leg/chest dynamometer to test muscle strength to assess performance status. Data analysis consisted of descriptive statistics, Pearson and Spearman &rgr; correlations, and multiple regression analysis using fatigue as the dependent variable. All P values were 2-sided, and P < .05 was considered significant. Results: Patients with newly diagnosed MM presented with fatigue, pain, sleep and mood disturbances, and diminished functional performance. The regression model, which included all of these variables along with age, sex, and stage of disease, was statistically significant with a large measure of effect. Mood was a significant individual contributor to the model. Conclusions: Among patients with MM, fatigue, pain, sleep, mood, and functional performance are interrelated. Implications for Practice: Interventions are needed to decrease fatigue and pain and to improve sleep, mood, and functional performance.
Oncology Nursing Forum | 2012
Elizabeth Ann Coleman; Julia A. Goodwin; Robert L. Kennedy; Sharon K. Coon; Kathy C. Richards; Carol A. Enderlin; Carol Beth Stewart; Paula McNatt; Kim Lockhart; Elias Anaissie
PURPOSE/OBJECTIVES To compare usual care with a home-based individualized exercise program (HBIEP) in patients receiving intensive treatment for multiple myeloma (MM)and epoetin alfa therapy. DESIGN Randomized trial with repeated measures of two groups (one experimental and one control) and an approximate 15-week experimental period. SETTING Outpatient setting of the Myeloma Institute for Research and Therapy at the Rockfellow Cancer Center at the University of Arkansas for Medical Sciences. SAMPLE 187 patients with newly diagnosed MM enrolled in a separate study evaluating effectiveness of the Total Therapy regimen, with or without thalidomide. METHODS Measurements included the Profile of Mood States fatigue scale, Functional Assessment of Cancer Therapy-Fatigue, ActiGraph® recordings, 6-Minute Walk Test, and hemoglobin levels at baseline and before and after stem cell collection. Descriptive statistics were used to compare demographics and treatment effects, and repeated measures analysis of variance was used to determine effects of HBIEP. MAIN RESEARCH VARIABLES Fatigue, nighttime sleep, performance (aerobic capacity) as dependent or outcome measures, and HBIEP combining strength building and aerobic exercise as the independent variable. FINDINGS Both groups were equivalent for age, gender, race, receipt of thalidomide, hemoglobin levels, and type of treatment regimen for MM. No statistically significant differences existed among the experimental and control groups for fatigue, sleep, or performance (aerobic capacity). Statistically significant differences (p < 0.05) were found in each of the study outcomes for all patients as treatment progressed and patients experienced more fatigue and poorer nighttime sleep and performance (aerobic capacity). CONCLUSIONS The effect of exercise seemed to be minimal on decreasing fatigue, improving sleep, and improving performance (aerobic capacity). IMPLICATIONS FOR NURSING Exercise is safe and has physiologic benefits for patients undergoing MM treatment; exercise combined with epoetin alfa helped alleviate anemia.
Plastic and Reconstructive Surgery | 2002
Sharon K. Coon; Rebecca Burris; Elizabeth Ann Coleman; Stephen J. Lemon
How health care providers deal with concerns and feelings of women who have problems with their breast implants affects the womens satisfaction with their breast implants, yet in 1992 little was known about the concerns and feelings of these women. A qualitative analysis of in-depth telephone interviews conducted in 1992 with 820 women from all regions of the United States who reported problems with their breast implants to the Food and Drug Administration and responded to an invitation to be interviewed provided data. Respondents were primarily 40 to 69 years of age at the time of interview, Caucasian, married, and educated beyond high school. The sample was almost equally divided in reason for breast implants, with 65 percent being dissatisfied with their breast implants. Nearly all of the women had heard of problems with silicone gel-filled implants. Their main sources of information were television, newspapers, and magazines rather than their physicians or the breast implant manufacturers. Some women tried to avoid hearing the reports, and many tried to put the reported problems out of their minds. However, a majority (88.7 percent) wanted more information. The women expressed feelings of anger, regret, and worry, and repeatedly said they needed more information. Women who contacted the Food and Drug Administration about breast implant problems needed accurate and honest information from health care professionals. They wanted their physicians to explore their symptoms, fears, and concerns.
Clinical Journal of Oncology Nursing | 2007
Sharon K. Coon; Judi McBride-Wilson; E. Ann Coleman
Ian was a patient with multiple myeloma. His wife, Judi, chronicled their journey and experiences with myeloma and the healthcare system. Through her own eyes, Judi provides a view of the positive and negative consequences of actions or omissions by the healthcare team. The other authors, oncology nurses affiliated with a myeloma treatment center, collaborated with Judi to tell her story and remind oncology nurses that they can and do make a difference when focus is placed on the basics: assessment, communication, caring, and follow-up.
Cancer Nursing | 2008
Elizabeth Ann Coleman; Sharon K. Coon; Julie Hall-Barrow; Kathy C. Richards; David Gaylor; Beth Stewart
We published an article BFeasibility of Exercise during Treatment for Multiple Myeloma[ in vol 26, no. 5, in 2003 in Cancer Nursing. This was a small feasibility/pilot study of 24 patients with a randomized controlled design to investigate home-based exercise therapy for patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantation. The effect of aerobic and strength resistance training on sleep, fatigue and mood, lean body weight, strength, and aerobic capacity was measured. Since then, we have received requests for the raw data or the means and SDs for pretest and posttest measures on each group. Because we are receiving more requests of this sort from researchers who want to include these data in a metaanalysis, we are providing the means, SDs, and percent change for each variable by group. It is not appropriate to just use means and SDs, as this is a small group of patients and the gender as well as thalidomide status would affect outcomes. Because of the small sample size, the effect of exercise on lean body weight was the only outcome measure that obtained statistical significance. However, the results suggest that aerobic and strength resistance training for patients receiving intensive treatment for multiple myeloma is safe, is feasible, and may be effective for decreasing fatigue and improving sleep. The table provides a summary of the data (see Table 1).
Clinical Journal of Oncology Nursing | 2003
Elizabeth Ann Coleman; Julie Hall-Barrow; Sharon K. Coon; Carol Beth Stewart
Clinical Journal of Oncology Nursing | 2009
Elizabeth Ann Coleman; Sharon K. Coon; Kimberly Lockhart; Robert L. Kennedy; Robert Montgomery; Nevada Copeland; Paula McNatt; Shelia Savell; Carol Beth Stewart
Oncology Nursing Forum | 2004
Sharon K. Coon; Elizabeth Ann Coleman